With the use of the FMH kit (BRAD3-FITC) and the flow cytometer the laboratory can accurately quantify the number of RhD positive cells in a mixture of RhD positive and negative cells. Therefore the possible fetal maternal haemorrhage can be analyzed in a maternal blood sample when a negative woman carries a RhD positive fetus. For optimal interpretation of the results the kit contains an anti-RhD antibody (BRAD 3) and a negative control antibody (AEVZ 5.3) both labelled with FITC.

• Based on flow cytometry
• Kit contains anti-RhD (BRAD 3) FITC and the control antibody (AEVZ 5.3) FITC
• Ready-to-use reagents
• Total assay time is 45 minutes, hands-on-time 15 minutes
• IVD/CE registered

This product is distributed by IQ Products for IBGRL, UK.